were Baht 370 million. The increase was due to drawdown of short-term loans of Baht 640 million and drawdown of long-term loans of Baht 318 million. The decrease was due to repayment of long-term loans
million and THB 5.71 million, respectively. The finance cost decreased by THB 0.97 million or 14.52% from the previous year due to repayment of loans from a financial institution in 2017. Net profit For the
). This was mainly due to net debenture repayment of Baht 3,100 million. Shareholders’ Equity As of 30 September 2019, the shareholders’ equity of the Company and its subsidiaries increased by Baht 150
Company will collect an additional 10% of the fee including a post-dated cheque (based on the credit term) for the remaining fees of 80% within November 2019, in order to prevent the risk of debt repayment
) shares to the Company as a security for the repayment of the said Loan Agreement in accordance with the Share Pledge Agreement dated 26 December 2016 ("Share Pledge Agreement"). Subsequently, the Company
the repayment in accordance with the contract and the duration o Liabilities under finance lease agreements totaling of Baht 29.03 Million, or increased of Baht 24.59 Million from previous year
construction of 2-storey buildings and the purchase of Hemodialysis machines. During the period, the loan was repayment according to the financial institution conditions. Provision for long-term employee
flow for the repayment. ( * source: article “Tourism as the driving vehicle for Thailand’s economy”, the Bank of Thailand) Q1/2020 financial highlight • Backlog1 of the Company and its subsidiaries stood
financing costs from bank loan repayment. Statement of Financial Position As at 31 March 2020, the Company had total assets of Bt3,432.22mn, decreasing 2.5% YoY, as a result of the Company’s strategy to
expenses were THB 32 million, a decrease of THB 1 million or 4.5% due to the loan repayment by ACM. In 1H/2020, financial expenses were THB 63 million, a decrease of THB 5 million or 7.4% due to the same